metastatic colorectal cancer

You have access
Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer
TETSUO ISHIZAKI, JUNICHI MAZAKI, MASANOBU ENOMOTO, MASATOSHI SHIGOKA, KENTA KASAHARA, TAKAAKI MATSUDO, HIDEAKI KAWAKITA, YUICHI NAGAKAWA, KENJI KATSUMATA and AKIHIKO TSUCHIDA

Anticancer Research April 2021, 41 (4) 2157-2163; DOI: https://doi.org/10.21873/anticanres.14988
You have access
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO and YASUHIRO SHIMADA

Anticancer Research April 2021, 41 (4) 2203-2207; DOI: https://doi.org/10.21873/anticanres.14996
You have access
Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib
MARIOS PAPADIMITRIOU and CHRISTOS A. PAPADIMITRIOU

Anticancer Research February 2021, 41 (2) 567-582; DOI: https://doi.org/10.21873/anticanres.14809
You have access
Effects of Type of Antibody to EGFR and Hypomagnesemia on Overall Survival in First-line Treatment of Patients With Unresectable Advanced/Recurrent Colorectal Cancer
MICHIO KIMURA, EISEKI USAMI and TOMOAKI YOSHIMURA

Anticancer Research December 2020, 40 (12) 7135-7140; DOI: https://doi.org/10.21873/anticanres.14743
You have access
Association of C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine-induced Toxicity in Mestizo Patients With Metastatic Colorectal Cancer
ALLAN RAMOS-ESQUIVEL, RICARDO CHINCHILLA and MARTA VALLE

Anticancer Research August 2020, 40 (8) 4263-4270; DOI: https://doi.org/10.21873/anticanres.14428
You have access
Comparison Between Biweekly and Weekly Cetuximab in Patients With Metastatic Colorectal Cancer: A Meta-analysis
AKIHISA MATSUDA, TAKESHI YAMADA, SUPASCHIN JAMJITTRONG, SEIICHI SHINJI, RYO OHTA, HIROMICHI SONODA, TUNYAPORN KAMONVARAPITAK, KUMIKO SEKIGUCHI, MASAO MIYASHITA, HIDEYUKI SUZUKI and HIROSHI YOSHIDA

Anticancer Research June 2020, 40 (6) 3469-3476; DOI: https://doi.org/10.21873/anticanres.14333
You have access
Risk Benefit of FOLFIRI Plus Ramucirumab as Third-line and Later-line Treatment of Metastatic Colorectal Cancer
MICHIO KIMURA, EISEKI USAMI, HITOMI TERAMACHI and TOMOAKI YOSHIMURA

Anticancer Research March 2020, 40 (3) 1605-1611; DOI: https://doi.org/10.21873/anticanres.14108
You have access
Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis
CARLO SIGNORELLI, MARIO GIOVANNI CHILELLI, ISABELLA SPERDUTI, SILVANA GIACINTI, PIETRO MARIA AMODIO, RAFFAELE MACARONE PALMIERI, TERESA VALENTINA RANALLI, VITO VINCENZO GOMES, MARIA ELENA ROSETTO, FABRIZIO NELLI and ENZO MARIA RUGGERI

Anticancer Research September 2019, 39 (9) 4917-4924; DOI: https://doi.org/10.21873/anticanres.13679
You have access
Pretreatment Neutrophil–to–Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer
AKIHISA MATSUDA, TAKESHI YAMADA, SATOSHI MATSUMOTO, NOBUYUKI SAKURAZAWA, YOUICHI KAWANO, ERIKO SHINOZUKA, KUMIKO SEKIGUCHI, HIDEYUKI SUZUKI and HIROSHI YOSHIDA

Anticancer Research August 2019, 39 (8) 4343-4350; DOI: https://doi.org/10.21873/anticanres.13602
You have access
The Onset of Grade ≥3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil
JACOPO GIULIANI and ANDREA BONETTI

Anticancer Research July 2019, 39 (7) 3967-3969; DOI: https://doi.org/10.21873/anticanres.13551

Main menu

User menu

Search

metastatic colorectal cancer

Pages